Pranitha Sambu
Pranitha Sambu has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Prasanna Kumar Lankalapalli
Visual Technologies LLC Plano Texas USA
4 shared publications Teja Kamireddy
Department of Engineering and Validation August Bioservices Nashville Tennessee USA
3 shared publicationsVijaykumar Chollety
Ascent Pharmaceuticals Inc Central Islip New York USA
3 shared publications- Hareesh Divadari
Stira Pharmaceuticals LLC Fairfield New Jersey USA
2 shared publications - Rama Krishna Myneni
Stira Pharmaceuticals LLC Fairfield New Jersey USA
2 shared publications Srinivasulu Kasa
Osmania University Hyderabad India
2 shared publications
Latest Publications
- 26 June 2025
- Published by Wiley in Biomedical Chromatography
- Vol. 39 (8) , e70109
Stability‐Indicating RP‐HPLC Method Development and Validation for the Quantification of Ketorolac Tromethamine‐Related Impurities in Tablets Solid Oral Dosage Forms
The present manuscript discusses the development and validation of a gradient reversed‐phase HPLC method for determining impurities in Ketorolac Tromethamine tablet dosage formulations. The analytes were separated using an Agilent Zorbax SB C8 column (250 × 4.6 mm, 5.0‐μm particle size). The mobile phase consisted of 0.05‐M ammonium phosphate buffer at pH 3.0 (mobile phase A) and a mixture of 40% methanol and 60% tetrahydrofuran (mobile phase B). The column temperature was maintained at 40°C, with a flow rate of 1.0 mL/min. UV detection was performed at 254 nm. The method demonstrated high specificity, with a linearity range of 0.201–6.445 μg/mL and achieving a correlation coefficient of > 0.999. The method exhibited high accuracy, exceeding 97%. The developed method was validated according to international ICH guidelines for specificity, linearity, precision, accuracy, and robustness. Stress studies indicated that Ketorolac Tromethamine tablets were sensitive to basic, photolytic, and oxidative stress conditions. The method was deemed suitable for quality control purposes, including impurity determination in Ketorolac Tromethamine tablets and stability‐indicating studies.
- 26 June 2025
- Published by Wiley in Biomedical Chromatography
- Vol. 39 (8) , e70109
Stability‐Indicating RP‐HPLC Method Development and Validation for the Quantification of Ketorolac Tromethamine‐Related Impurities in Tablets Solid Oral Dosage Forms
The present manuscript discusses the development and validation of a gradient reversed‐phase HPLC method for determining impurities in Ketorolac Tromethamine tablet dosage formulations. The analytes were separated using an Agilent Zorbax SB C8 column (250 × 4.6 mm, 5.0‐μm particle size). The mobile phase consisted of 0.05‐M ammonium phosphate buffer at pH 3.0 (mobile phase A) and a mixture of 40% methanol and 60% tetrahydrofuran (mobile phase B). The column temperature was maintained at 40°C, with a flow rate of 1.0 mL/min. UV detection was performed at 254 nm. The method demonstrated high specificity, with a linearity range of 0.201–6.445 μg/mL and achieving a correlation coefficient of > 0.999. The method exhibited high accuracy, exceeding 97%. The developed method was validated according to international ICH guidelines for specificity, linearity, precision, accuracy, and robustness. Stress studies indicated that Ketorolac Tromethamine tablets were sensitive to basic, photolytic, and oxidative stress conditions. The method was deemed suitable for quality control purposes, including impurity determination in Ketorolac Tromethamine tablets and stability‐indicating studies.
- 26 May 2025
- Published by Wiley in Biomedical Chromatography
- Vol. 39 (7) , e70103
Stability‐Indicating RP‐HPLC Method Development and Validation for Quantification of Butylated Hydroxyanisole Content in Loperamide Oral Solid Dosage Form
The present study discusses the development of a simple, rapid, and specific high‐performance liquid chromatography (HPLC) method for the estimation of butylated hydroxyanisole (BHA) in loperamide HCl capsule dosage formulations. The developed HPLC method was validated in accordance with current ICH guidelines. Chromatographic separation was achieved using a phosphate buffer (pH 6.8) as mobile phase A and a mixture of acetonitrile and buffer in a ratio of 80:20 (v/v) as mobile phase B. The flow rate was 0.8 mL/min, and column temperature was maintained at 35°C. Detection of the component was performed at 290 nm for BHA. The optimized HPLC method was validated as per current ICH guidelines and demonstrated high specificity with a linearity range of 13–83 μg/mL for BHA, with a correlation coefficient greater than 0.999. The method showed accuracy exceeding 97%. Stress studies revealed that BHA is sensitive to peroxide stress conditions. The results highlight the successful applicability of the current method for estimating BHA in marketed formulations, which can be further utilized to evaluate other formulation systems. The developed method was validated according to international ICH guidelines concerning specificity, linearity, precision, and accuracy. The method was developed and validated in a quality control lab for stability analysis.
- 26 May 2025
- Published by Wiley in Biomedical Chromatography
- Vol. 39 (7) , e70103
Stability‐Indicating RP‐HPLC Method Development and Validation for Quantification of Butylated Hydroxyanisole Content in Loperamide Oral Solid Dosage Form
The present study discusses the development of a simple, rapid, and specific high‐performance liquid chromatography (HPLC) method for the estimation of butylated hydroxyanisole (BHA) in loperamide HCl capsule dosage formulations. The developed HPLC method was validated in accordance with current ICH guidelines. Chromatographic separation was achieved using a phosphate buffer (pH 6.8) as mobile phase A and a mixture of acetonitrile and buffer in a ratio of 80:20 (v/v) as mobile phase B. The flow rate was 0.8 mL/min, and column temperature was maintained at 35°C. Detection of the component was performed at 290 nm for BHA. The optimized HPLC method was validated as per current ICH guidelines and demonstrated high specificity with a linearity range of 13–83 μg/mL for BHA, with a correlation coefficient greater than 0.999. The method showed accuracy exceeding 97%. Stress studies revealed that BHA is sensitive to peroxide stress conditions. The results highlight the successful applicability of the current method for estimating BHA in marketed formulations, which can be further utilized to evaluate other formulation systems. The developed method was validated according to international ICH guidelines concerning specificity, linearity, precision, and accuracy. The method was developed and validated in a quality control lab for stability analysis.
- 7 February 2025
- Published by Wiley in Biomedical Chromatography
- Vol. 39 (3) , e6088
Stability‐Indicating RP‐HPLC Method Development and Validation for the Quantification of Fluphenazine Tablets in Solid Oral Dosage Form
The present manuscript discusses the development of simple, rapid, specific, precision, accuracy stability indicating HPLC method for the analysis of fluphenazine tablets dosage form. The chromatographic separation was achieved using 0.02‐M phosphate buffer (pH 3.0) and adjusted with orthophosphoric acid solution as a buffer. We mixed buffer, methanol, and acetonitrile in the ratio of 500:300:200 (v/v/v) as the mobile phase. The detection of component was made at 254 nm for fluphenazine hydrochloride. We evaluated stress studies under different types of ICH conditions. The optimized HPLC method was validated as per the current ICH guidelines. The validated HPLC method was obtained highly specific with linearity ranging between 2.5 and 120 μg/mL of fluphenazine HCl and the correlation coefficient for the drug > 0.999. The method showed more than 97% accuracy. In stress studies, the fluphenazine HCl was found to be sensitive in photolytic stress conditions and oxidation stress condition. It is a typical antipsychotic drug and used for the treatment of schizophrenia and bipolar disorder. The method was found to be suitable for the quality control of fluphenazine hydrochloride in the tablet as well as in stability‐indicating studies. The method was applied to analyze stability samples.
- 7 February 2025
- Published by Wiley in Biomedical Chromatography
- Vol. 39 (3) , e6088
Stability‐Indicating RP‐HPLC Method Development and Validation for the Quantification of Fluphenazine Tablets in Solid Oral Dosage Form
The present manuscript discusses the development of simple, rapid, specific, precision, accuracy stability indicating HPLC method for the analysis of fluphenazine tablets dosage form. The chromatographic separation was achieved using 0.02‐M phosphate buffer (pH 3.0) and adjusted with orthophosphoric acid solution as a buffer. We mixed buffer, methanol, and acetonitrile in the ratio of 500:300:200 (v/v/v) as the mobile phase. The detection of component was made at 254 nm for fluphenazine hydrochloride. We evaluated stress studies under different types of ICH conditions. The optimized HPLC method was validated as per the current ICH guidelines. The validated HPLC method was obtained highly specific with linearity ranging between 2.5 and 120 μg/mL of fluphenazine HCl and the correlation coefficient for the drug > 0.999. The method showed more than 97% accuracy. In stress studies, the fluphenazine HCl was found to be sensitive in photolytic stress conditions and oxidation stress condition. It is a typical antipsychotic drug and used for the treatment of schizophrenia and bipolar disorder. The method was found to be suitable for the quality control of fluphenazine hydrochloride in the tablet as well as in stability‐indicating studies. The method was applied to analyze stability samples.
- 19 November 2024
- Published by Wiley in Biomedical Chromatography
- Vol. 39 (1) , e6048
A Simple and Rapid HPLC Method Development for Quantification of Sodium Benzoate Content in Chlorzoxazone Oral Solid Dosage Forms
The present study discusses the development of a simple, rapid, and specific HPLC method for the estimation of sodium benzoate in chlorzoxazone tablet dosage formulations. The current developed HPLC method was validated as per the current ICH guidelines. The chromatographic separation was achieved using a 0.02‐M phosphate buffer adjusted to pH 3.0 with orthophosphoric acid as the buffer. Mobile phase A consisted of 100% buffer, and mobile phase B was a mixture of acetonitrile and buffer in a ratio of 80:20 (v/v). The column temperature was maintained at 30°C, the sample cooler at 25°C, and the flowrate at 0.8 mL min−1. The injection volume was 10 μL. The UV detection was performed at 230 nm for Sodium benzoate. The validated HPLC method was highly specific, with linearity ranging between 1.2 and 7.5 μg/mL for sodium benzoate, and the correlation coefficient was found to be > 0.999. The method showed high accuracy, exceeding 97%. The results demonstrate the successful applicability of the current method for the estimation of sodium benzoate in marketed formulations, which can be extended to assess other formulation systems. The developed method was validated as per international ICH guidelines with respect to specificity, linearity, precision, accuracy, and robustness. The method was applied to the analysis of stability samples.
- 19 November 2024
- Published by Wiley in Biomedical Chromatography
- Vol. 39 (1) , e6048
A Simple and Rapid HPLC Method Development for Quantification of Sodium Benzoate Content in Chlorzoxazone Oral Solid Dosage Forms
The present study discusses the development of a simple, rapid, and specific HPLC method for the estimation of sodium benzoate in chlorzoxazone tablet dosage formulations. The current developed HPLC method was validated as per the current ICH guidelines. The chromatographic separation was achieved using a 0.02‐M phosphate buffer adjusted to pH 3.0 with orthophosphoric acid as the buffer. Mobile phase A consisted of 100% buffer, and mobile phase B was a mixture of acetonitrile and buffer in a ratio of 80:20 (v/v). The column temperature was maintained at 30°C, the sample cooler at 25°C, and the flowrate at 0.8 mL min−1. The injection volume was 10 μL. The UV detection was performed at 230 nm for Sodium benzoate. The validated HPLC method was highly specific, with linearity ranging between 1.2 and 7.5 μg/mL for sodium benzoate, and the correlation coefficient was found to be > 0.999. The method showed high accuracy, exceeding 97%. The results demonstrate the successful applicability of the current method for the estimation of sodium benzoate in marketed formulations, which can be extended to assess other formulation systems. The developed method was validated as per international ICH guidelines with respect to specificity, linearity, precision, accuracy, and robustness. The method was applied to the analysis of stability samples.
- 26 September 2024
- Published by Wiley in Biomedical Chromatography
- Vol. 38 (12) , e6017
Stability‐indicating RP‐HPLC method development and validation for the quantification of amlodipine besylate and valsartan tablets in solid oral dosage form
The present study discusses the development of simple, rapid, specific, precision, accuracy, stability indicating the HPLC method for the analysis of amlodipine besylate and valsartan tablet dosage form. The chromatographic separation was achieved using phosphate buffer with 1% triethyl amine (pH 3.0) as mobile phase‐A and mixed Methanol and buffer in the ratio of (65:35)(v/v) as mobile phase‐B. The detection of components was made at 237 nm for amlodipine besylate and valsartan. Analytical techniques should enrich sensitivity and specificity for the estimation of pharmaceutical drug products. Evaluated stress studies under different types of ICH conditions. The optimized HPLC method was validated as per the current ICH guidelines. The validated HPLC method was obtained highly specific with linearity ranging between 25 and 200 μgmL−1 of amlodipine besylate and 40–320 μgmL−1 of valsartan and both components correlation coefficient was > 0.999. The method showed high accuracy more than 97%. In stress studies, amlodipine besylate and valsartan were found to be sensitive to acid stress conditions and oxidation stress conditions. The method was found to be suitable for the quality control of amlodipine besylate and valsartan in the tablet as well as in stability‐indicating studies. The method was applied to the analysis of stability samples.
- 26 September 2024
- Published by Wiley in Biomedical Chromatography
- Vol. 38 (12) , e6017
Stability‐indicating RP‐HPLC method development and validation for the quantification of amlodipine besylate and valsartan tablets in solid oral dosage form
The present study discusses the development of simple, rapid, specific, precision, accuracy, stability indicating the HPLC method for the analysis of amlodipine besylate and valsartan tablet dosage form. The chromatographic separation was achieved using phosphate buffer with 1% triethyl amine (pH 3.0) as mobile phase‐A and mixed Methanol and buffer in the ratio of (65:35)(v/v) as mobile phase‐B. The detection of components was made at 237 nm for amlodipine besylate and valsartan. Analytical techniques should enrich sensitivity and specificity for the estimation of pharmaceutical drug products. Evaluated stress studies under different types of ICH conditions. The optimized HPLC method was validated as per the current ICH guidelines. The validated HPLC method was obtained highly specific with linearity ranging between 25 and 200 μgmL−1 of amlodipine besylate and 40–320 μgmL−1 of valsartan and both components correlation coefficient was > 0.999. The method showed high accuracy more than 97%. In stress studies, amlodipine besylate and valsartan were found to be sensitive to acid stress conditions and oxidation stress conditions. The method was found to be suitable for the quality control of amlodipine besylate and valsartan in the tablet as well as in stability‐indicating studies. The method was applied to the analysis of stability samples.